Beijing Tong Ren Tang Chinese Medicine Company Limited (TONGRENTANGCM) filed its Monthly Return with Hong Kong Exchanges and Clearing on 3 June 2026, covering movements in securities for the month ended 31 May 2026.
The filing shows the company’s issued share capital remained steady at 837.10 million ordinary shares, with zero treasury shares recorded. No share issuance, repurchase, cancellation, or conversion activity took place during the period.
Management confirmed compliance with Main Board Rule 13.32D, indicating the public float comfortably met the minimum 25% requirement as at 31 May 2026.
The return also notes that there were no outstanding share options, warrants, convertible securities, or other agreements that could dilute the current share base.